MINNEAPOLIS/ST. PAUL (09/28/2022) Published in Leukemia Research, University of Minnesota Medical School researchers explored the possible biological mechanisms that could explain the association between being overweight or obese prior to pregnancy and the increased risk of acute lymphoblastic leukemia (ALL) in children. 

“Recent research has found that increasing rates of overweight and obesity among people of childbearing age in recent decades may be contributing to concurrently increasing rates of pediatric acute lymphoblastic leukemia,” said Andrew Marley, MPH, PhD, a postdoctoral fellow at the U of M Medical School. “However, it is unknown how maternal obesity may be impacting ALL development.”

Researchers say explanations for this possible increased risk include:

  • Changes in fetal or newborn epigenetics — or behavioral and environmental factors that can affect the way genes work. 

  • Altered insulin-like growth factor profiles and insulin resistance.

  • Modified adipokine — or cell signaling proteins from adipose tissue — production and secretion. 

  • Changes to immune cell populations.

  • Impacts on birthweight and childhood body weight.

The research team stated each of these mechanisms have biologically sound reasoning because they are impacted by obesity, can be observed in fetuses or newborns, and have been documented in pediatric ALL patients at diagnosis. They have also been linked with ALL development.

“This review is important because if we identify the mechanisms behind this association, we can provide better and more tailored approaches to treatment and prevention,” Dr. Marley said. 

Although the reasons for an association between obesity prior to pregnancy and leukemia development in children have been proposed, evidence remains circumstantial. Further research is suggested to find a biological signature connecting pre-pregnancy overweight and obesity to leukemia risk in children. Researchers say more specific epidemiological and clinical research could help provide a better understanding of the association and improve future prevention and treatment efforts. 

Research was supported by the National Cancer Institute (T32 CA099936).


About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. We acknowledge that the U of M Medical School, both the Twin Cities campus and Duluth campus, is located on traditional, ancestral and contemporary lands of the Dakota and the Ojibwe, and scores of other Indigenous people, and we affirm our commitment to tribal communities and their sovereignty as we seek to improve and strengthen our relations with tribal nations. For more information about the U of M Medical School, please visit med.umn.edu